Join Insilico Medicine at NeurIPS 2025: Unveiling Generative AI Breakthroughs Revolutionizing Drug Discovery and Development (IMAGE)

InSilico Medicine

Join Insilico Medicine at NeurIPS 2025: Unveiling Generative AI Breakthroughs Revolutionizing Drug Discovery and Development

Caption

Led by Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine, and Petrina Kamya, PhD, Global Head of AI Platforms, Insilico’s experienced team will participate in the conference.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.